supply chain finance models part 1: bank-agnostic models, bank-funded and managed approaches

22
Supply Chain Financing Bank Funded Solution Stephen KunzDirector of Corporate Finance, Working Capital Lead [email protected] Sean McDermott Manager, North America Accounts Payable CBS [email protected]

Upload: sharedserviceslinkcom

Post on 05-Apr-2017

120 views

Category:

Education


3 download

TRANSCRIPT

Supply Chain Financing – Bank Funded

Solution

Stephen Kunz– Director of Corporate Finance, Working Capital Lead

[email protected]

Sean McDermott – Manager, North America Accounts Payable CBS

[email protected]

Agenda:

GSK - Who we are

Strategic priorities

Structure

External view

Working capital program

Bank funded supply chain solution

Lessons learned

Questions

GlaxoSmithKline Mission

Agenda:

GSK - Who we are

Strategic priorities

Structure

External view

Working capital program

Bank funded supply chain solution

Lessons learned

Questions

Strategic priorities

Our business is focused around the delivery of five strategic

priorities, which aim to increase growth, reduce risk and improve

our long term financial performance

Agenda:

GSK - Who we are

Strategic priorities

Structure

External view

Working capital program

Bank funded supply chain solution

Lessons learned

Questions

GSK Structure

Finance

Business Service Centers

Business Process

Outsourcing

North

America

Europe

Asia

Pacific

HR

Procure

-ment

Real

Estate

IT

CBS

R

E

G

I

O

N

A

L

G

L

O

B

A

L

Working

Capital Team

Agenda:

GSK - Who we are

Strategic priorities

Structure

External view

Working capital program

Bank funded supply chain solution

Lessons learned

Questions

Cash Cycle Performance - External View

Progress Versus Benchmarks - Ranked by 2010 Performance

Days Inventory Outstanding Days Sales Outstanding Days Payable Outstanding

308

243

232

224

203

201

190

186

161

146

120

98

92

62

Novo Nordisk

Pfizer-Wyeth

Merck-SGP

Eli-Lilly

GSK 2008

GSK 2009

GSK 2010

Sanofi

Novartis

Roche

Bayer

AstraZeneca

Bristol Myers

Unilever

79

76

75

70

67

66

66

66

66

62

55

54

47

31

Pfizer-Wyeth

Roche

GSK 2008

GSK 2009

Sanofi

GSK 2010

Novartis

Bayer

AstraZeneca

Bristol Myers

Merck-SGP

Eli-Lilly

Novo Nordisk

Unilever

2010 Data from published reports and Citigroup Investment Research and Analysis

13

21

23

24

26

26

29

36

37

37

42

46

47

55

Roche

GSK 2008

Eli-Lilly

Novo Nordisk

Merck-SGP

GSK 2009

GSK 2010

Bayer

Pfizer-Wyeth

AstraZeneca

Novartis

Sanofi

Unilever

Bristol Myers

10

GSK 2011

GSK 2011

GSK 2011

161

61

192

43

Evolution of Working Capital Efficiency 2008 – 2011

Dec-2008 Dec-2009 Dec-2010 Dec-2011

DSO 75 70 66 61

DPO 21 26 35 43

DIO 203 200 190 192

Total CCC 257 224 221 210

WCAP

% of Sales 34% 27% 23% 21%

2011 FY Investor / Analyst Results Presentation

Agenda:

GSK - Who we are

Strategic priorities

Structure

External view

Working capital program

Bank funded supply chain solution

Lessons learned

Questions

GSK - DPO Journey to Best in Class

Key Activities:

–Centralized Working Capital Team

–Procurement

–Finance

– Standard Terms

– Payment from Receipt of Invoice

–Contract Terms to Spend Actual

– Supplier Rationalization

– Supply Chain Finance Program

0

5

10

15

20

25

30

35

40

45

50

2009 2010 2011

DPO

DPO

Keeping Your Business Partners Happy

• Terms and Conditions.

• Payables Process. Communication

• Efficient receipt and processing of invoices.

• Supplier visibility of payment process.

Streamlined Payables

Operations

• Supply Chain Financing

• Discounting Programs

• Procurement Card Spend

Multiple Solutions

Agenda:

GSK - Who we are

Strategic priorities

Structure

External view

Working capital program

Bank funded supply chain solution

Lessons learned

Questions

17

Supply Chain Financing - Bank Model Process

SUPPLIERS

E-Invoicing Portal

Invoice Data

Sent to Bank

Supplier decides to

accelerate

payment and paid

by bank

Payment is made to bank based on

suppliers terms.

Invoice

Submission

Invoice

Receipt and

Approval

Program Implementation

Supplier Engagement

• Internal Champions

• Identify suppliers

• Communicate Benefits:

• Accelerate DSO

• Alternative Source of liquidity at a potentially lower cost

• Manage cash flow needs

Supplier onboarding

• Collaboration required between all parties.

• Agree Strategy

• Complete Legal and Technology activities

• Provide Training

• Process overview.(internal)

Go Live

• Ensure internal process is well documented.

• Monitor program suppliers

Agenda:

GSK - Who we are

Strategic priorities

Structure

External view

Working capital program

Bank funded supply chain solution

Lessons learned

Questions

Key Learning and Takeaways

Learnings:

– Ensure payables process is streamlined.

– Key business partners need to be educated when their supplier moves onto the

program.

–Change in process rules internally must be identified

–Change in company policy need to be communicated to bank.

Takeaways:

–Communication with you bank partner is critical.

–Understanding at the operation teams who is the key contacts.

– Ensure your suppliers are betting the benefit!

Agenda:

GSK - Who we are

Strategic priorities

Structure

External view

Working capital program

Bank funded supply chain solution

Lessons learned

Questions

Stephen Kunz– Director of Corporate Finance Working Capital Lead

[email protected]

Sean McDermott – Manager, North America Accounts Payable CBS

[email protected]